Biography

Michael Dowling, M.D., Ph.D. is a Pediatric Neurologist who specializes in pediatric stroke and neurovascular disorders as well as the neurologic complications of sickle cell disease. He came to UT Southwestern to complete his Pediatric and Pediatric Neurology fellowship training after completing his A.B. at Harvard College (Biochemistry and Molecular Biology, cum laude), and completing his M.D. and Ph.D. (Biochemistry) at Columbia University where he had the remarkable experience of completing graduate courses with two subsequent Nobel Laureates, Martin Chalfie and Eric Kandel and completing his doctoral dissertation with subsequent Nobel Laureates Richard Axel and Linda Buck, cloning and characterizing olfactory receptors. He gained additional training in clinical research as NIH/NHLBI-funded Sickle Cell Scholar and then as a member of the UTSW Clinical Scholars (K12/KL2) program, obtaining a Master’s of Science in Clinical Sciences, with distinction, from UTSW in 2009. He was promoted to Associate Professor of Pediatrics and Neurology and Neurotherapeutics in 2012.

Dr. Dowling has created one of the largest and most productive clinical and research programs for pediatric stroke in the country. He established a Pediatric Stroke clinic in 2003, the Pediatric Acute Stroke team in 2004, and co-authored clinical guidelines for the evaluation and management of children with stroke in for Children’s Medical Center and subsequent revisions and established an ACGME-accredited post graduate fellowship program in Pediatric stroke. Dr. Dowling is also a founding member of the Center for Cerebrovascular Disorders in Children (CCDC) at Children’s Health (in 2016) a collaborative group of neurologists, neurosurgeons, hematologists and neuroradiologists formed to improve the clinical care to children with stroke and other cerebrovascular disorders and includes a monthly clinical pediatric neurovascular conference for case review and education. His research focuses on stroke in children and the neurologic complications of sickle cell disease. He is an active member and lead enroller in the International Pediatric Stroke Study, with over 450 patients of the >5000 total enrolled at 65 centers around the world.  Dr. Dowling was first author of one of the primary analyses of the dataset, cardiac causes of stroke. He currently serves on the IPSS Publication Committee and participates in many other multicenter studies.

He also has a long-standing interest in ethical issues in neurology. He is a member of the Children’s Ethics Committee (since 2006) and served on the Ethics Committee of the Child Neurology Society from 2012-2016 and served as Topic Chair for the American Academy of Neurology Annual Meeting Sessions on Ethics in 2008-2011. In an ongoing educational innovation with students and residents, since 2007, he has actively engaged over 600 medical students on service in the clinic. This included a reading assignment of the play, Joe Egg, by Peter Nichols, which explores the difficulties encountered by parents caring for a child with a severe brain injury and intractable epilepsy. He has developed and presented Ethics CME lectures at multiple venues on separate topics of ethical concerns in pediatric gene therapy, brain death, and the care of neurologically devastated children.

Education

Graduate School
Columbia University in the City of New York (1989)
Graduate School
Columbia University in the City of New York (1993)
Medical School
Columbia University (1995)
Internship
Children's Health Dallas (1996), Pediatrics
Residency
Children's Health Dallas (1997), Pediatrics
Residency
UT Southwestern Medical Center (2000), Pediatric Neurology
Graduate School
UT Southwestern Medical Center (2009)

Research Interest

  • Alternative etiologies for stroke in sickle cell disease
  • Cerebrovascular disease
  • Neurologic complications of sickle cell disease
  • Neurologic injury in children with acute anemia
  • Pediatric stroke
  • Sturge-Weber syndrome

Publications

Featured Publications LegendFeatured Publications

Characteristics and Outcome in Children With Craniectomy Following Acute Ischemic Stroke in the International Pediatric Stroke Study.
Lehman LL, DeVeber G, Pergami P, Guilliams KP, Chung M, Felling R, Dowling MM, Rivkin MJ, J. Child Neurol. 2019 Jul 883073819855534
Arterial Ischemic Stroke Secondary to Cardiac Disease in Neonates and Children.
Chung MG, Guilliams KP, Wilson JL, Beslow LA, Dowling MM, Friedman NR, Hassanein SMA, Ichord R, Jordan LC, Mackay MT, Rafay MF, Rivkin M, Torres M, Zafeiriou D, deVeber G, Fox CK, Pediatr. Neurol. 2019 Jun
Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management.
Guilliams KP, Kirkham FJ, Holzhauer S, Pavlakis S, Philbrook B, Amlie-Lefond C, Noetzel MJ, Dlamini N, Sharma M, Carpenter JL, Fox CK, Torres M, Ichord RN, Jordan LC, Dowling MM, Stroke 2019 May 50 5 1089-1094

Books

Featured Books Legend Featured Books

Honors & Awards

  • Pediatric Neurology Resident Teaching Award "Golden Boots"
    (2018)
  • Texas Super Doctors
    Texas Monthly Magazine (2017)
  • Best Pediatric Specialists/Doctors in Dallas
    D Magazine (2010-2013) (2015-2018)
  • Alpha Omega Alpha Honor Medical Society Award
    (2014)
  • Trephined Cranium Award for Outstanding Teaching
    UT Southwestern Medical Center (2014)
  • 8th Annual Excellence in Teaching Award
    UT Southwestern Medical Center (2012)
  • Core Clerkship Teaching Award
    UT Southwestern Medical Center (2009)
  • Innovations in Clinical Research Award
    Doris Duke Charitable Foundation (2009)

Professional Associations/Affiliations

  • American Heart Association/American Stroke Association (2007)
  • Child Neurology Society (2002)
  • American Academy of Neurology (2001)
  • Fellow, American Academy of Neurology